Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma

NCT01482520 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01482520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01482520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
October 31, 2013
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, renal cell carcinoma